Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
Completed
1,892 enrolled
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
Completed
1,340 enrolled
Imaging in MGUS, SMM and MM
Phase 2 Completed
31 enrolled 13 charts
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Phase 1/2 Completed
34 enrolled 18 charts
Ixazomib and Pevonedistat in Treating Patients With Multiple Myeloma That Has Come Back or Does Not Respond to Treatment
Phase 1 Completed
8 enrolled 11 charts
Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial
Phase 3 Completed
1 enrolled 1 chart
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy
Phase 2 Completed
19 enrolled 18 charts
Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 1 Completed
12 enrolled
Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)
Phase 2 Completed
203 enrolled 25 charts
Vaccine Therapy in Treating Patients With Multiple Myeloma
Phase 2 Completed
Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)
Phase 2 Completed
57 enrolled 22 charts
BMT CTN 0702
Phase 3 Completed
758 enrolled 21 charts
BMT CTN 0102
Phase 3 Completed
710 enrolled 19 charts
T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma
Phase 1 Completed
13 enrolled 15 charts
Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W)
Phase 2 Completed
52 enrolled 10 charts
Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant
Phase 1 Completed
71 enrolled
Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D)
Phase 2 Completed
47 enrolled 10 charts
Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)
Phase 3 Completed
273 enrolled 16 charts
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
Phase NA Completed
41 enrolled
A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies
Phase 1 Completed
16 enrolled
Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma
Phase 1 Completed
30 enrolled 13 charts
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
Phase 2 Completed
16 enrolled 11 charts
Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Phase 1/2 Completed
92 enrolled 28 charts
The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers
Phase 2 Completed
102 enrolled
Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants
Phase 1 Completed
110 enrolled
Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Phase 1 Completed
41 enrolled
Collection of Transplant Stem Cells for Plasma Cell Myeloma
Phase 2 Completed
49 enrolled 17 charts
Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma
Phase 2 Completed
39 enrolled 10 charts
Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
Phase 2 Completed
23 enrolled 7 charts
Blood and Marrow Transplant Clinical Research Network
Phase NA Completed
AZD6244 (Selumetinib) in Treating Patients With Multiple Myeloma
Phase 2 Completed
37 enrolled 9 charts
Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
Phase NA Completed
Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 1 Completed
12 enrolled
FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2 Completed
50 enrolled
Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
Phase 1 Completed
93 enrolled
Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma
Phase 1 Completed
50 enrolled
Sunitinib in Treating Patients With Relapsed Multiple Myeloma
Phase 2 Completed
13 enrolled 7 charts
Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase 3 Completed
Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma
Phase 1/2 Completed
56 enrolled
Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 3 Completed
Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma
Phase 2 Completed
30 enrolled
Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase 2 Completed
35 enrolled
Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma
Phase 1/2 Completed
30 enrolled
Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2 Completed
25 enrolled
Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma
Phase 1 Completed
25 enrolled
Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 1 Completed
36 enrolled
Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure
Phase 3 Completed
280 enrolled
Combination Chemotherapy in Treating Patients With Multiple Myeloma
Phase 2 Completed
Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma
Phase 2 Completed
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer
Phase 2 Completed